VRSK
25
-3
VLO
48
-2
LH
48
-2
URBN
70
-4
MET
64
-2
IFF
53
2
OI
50
-6
AEP
59
-5
CF
42
-6
RCL
73
-3
CINF
63
-3
RSG
50
-4
ADT
48
-2
WHR
50
-5
SWK
52
-6
NI
65
-2
MCHP
45
-4
ESS
39
-5
RIG
35
-6
JBHT
63
-2
VRSK
25
-3
VLO
48
-2
LH
48
-2
URBN
70
-4
MET
64
-2
IFF
53
2
OI
50
-6
AEP
59
-5
CF
42
-6
RCL
73
-3
CINF
63
-3
RSG
50
-4
ADT
48
-2
WHR
50
-5
SWK
52
-6
NI
65
-2
MCHP
45
-4
ESS
39
-5
RIG
35
-6
JBHT
63
-2
Financhill
Back

Mackenzie Emerging Markets Equity Index ETF Vs. Aligos Therapeutics, Inc. Industry Stock Comparison

Sell
50

QEE.TO
Mackenzie Emerging Markets Equity Index ETF

Last Price:
$116.76
Seasonality Move:
2.21%
Buy
73

ALGS
Aligos Therapeutics, Inc.

Last Price:
$11.37
Seasonality Move:
-2.85%
Sell
50
Mackenzie Emerging Markets Equity Index ETF (QEE.TO) is a Sell

Is Mackenzie Emerging Markets Equity Index ETF a Buy, Sell or Hold?

  • The current Mackenzie Emerging Markets Equity Index ETF [QEE.TO] share price is $116.76. The Score for QEE.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • QEE.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Aligos Therapeutics, Inc. (ALGS) is a Buy

Is Aligos Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Aligos Therapeutics, Inc. [ALGS] share price is $11.47. The Score for ALGS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QEE.TO Stock Price Chart

What is Mackenzie Emerging Markets Equity Index ETF's stock price today?

  • The Mackenzie Emerging Markets Equity Index ETF share price today is $116.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QEE.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics, Inc.'s stock price today?

  • The Aligos Therapeutics, Inc. share price today is $11.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

QEE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 33.47 Sell
Chaikin Money Flow: 621 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.92 Buy
Relative Strength Index (14 RSI): 61.05 Buy
Chaikin Money Flow: -12024 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.55 - 11.25) Buy
Bollinger Bands (100): (7.91 - 10.77) Buy

QEE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.81 Sell
20-day SMA: 119.38 Sell
50-day SMA: 120.44 Sell
200-day SMA: 107.85 Buy
8-day EMA: 118.5 Sell
20-day EMA: 119.36 Sell
50-day EMA: 119 Sell
200-day EMA: 110.33 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.43 Buy
20-day SMA: 10.11 Buy
50-day SMA: 9.23 Buy
200-day SMA: 8.41 Buy
8-day EMA: 11.42 Buy
20-day EMA: 10.37 Buy
50-day EMA: 9.59 Buy
200-day EMA: 10.54 Buy

Mackenzie Emerging Markets Equity Index ETF Earnings Growth & QEE.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics, Inc. Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.

Mackenzie Emerging Markets Equity Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):